TRPV2 and urinary bladder cancer: In this context, the expression of transient receptor potential vanilloid 2 (TRPV2), one of the key genes in the NOD-like receptor signaling pathway, was significantly increased in bladder cancer cells after GPD1 overexpression (Fig. 4D, E).